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Introduction
Attention deficits may affect the ability of older adults to 
engage in rehabilitation poststroke.1 In addition, fatigue is 
very common poststroke. Fatigue is a complex impairment. 
Reduced cortical excitability is postulated to be one factor 
contributing to poststroke fatigue.2 Thus, fatigue and atten-
tional decline may limit rehabilitation therapy session dura-
tion in older adults poststroke.1,2 Because rehabilitation is 
typically offered only in the initial months poststroke, it is 
critical that stroke survivors engage in as much therapy as 
possible during this time. The mean physiotherapy session 
treatment duration in a large published series was 38 ± 17 
minutes.3 We identified that many patients, particularly those 
with severe stroke, are not able to stay alert for the duration of 
their therapy sessions and often cannot complete their ther-
apy due to fatigue, attentional decline, or loss of concentra-
tion. In local audit data, the mean session duration of therapy 
sessions among 14 stroke survivors in the Bentley Hospital 
Stroke Rehabilitation Unit (SRU) was 34 ± 23 minutes. 
These published international data, and our local data, are 
both far below the recommended durations of rehabilitation 
therapy (at least 3 hours a day of scheduled therapy)4 suggest-
ing the importance of investigating interventions that can 
improve duration and the number of therapy sessions.
There is preliminary evidence that noninvasive brain stimu-
lation (NIBS) can enhance alertness and attention post-
stroke.5,6 Compared with other NIBS techniques such as 
repetitive transcranial magnetic stimulation, transcranial direct 
current stimulation (tDCS) offers a reliable safety profile,7 
affordability, ease of application, and sophisticated sham mode 
which allows for blinded control in clinical trial settings.8 
Transcranial direct current stimulation is one of the most com-
monly used adjuvant NIBS techniques and has been shown to 
augment the recovery of upper limb movement and function 
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and to assist in the management of dysphasia, visual neglect, 
and language dysfunction poststroke.9
Transcranial direct current stimulation acts to modulate 
cortical excitability by application of weak electrical currents 
(up to 2 mA)10 via electrodes applied to the scalp. Depending 
on the current polarity, neuronal firing rates increase or decrease 
due to changes in resting membrane potentials, with anodal 
tDCS increasing the likelihood of neuronal firing and cathodal 
tDCS decreasing the likelihood of neuronal firing.11 It has 
been shown to be safe even when applied acutely (within two 
days) to the stroke-affected cortex.12 Previous research has 
shown stroke survivors demonstrated greater accuracy, but not 
speed, on a test of executive attention following one session of 
tDCS compared with sham stimulation.5,6 The application of 
tDCS to the DLPFC has been shown to enhance cognitive 
functions including working memory, visuomotor coordina-
tion, and decision-making in healthy individuals,13,14 and in 
people with dementias or Parkinson disease.15-17 The after-
effects of tDCS on cortical excitability are likely modulated by 
N-methyl-d-aspartate (NMDA) receptor-dependent pro-
cesses, and a number of investigations have shown that longer 
term changes can be induced in neuronal networks, including 
cognitive-attentional networks.9
The main adverse effect of tDCS which has been docu-
mented include a mild tingling or itching sensation, usually at 
the site of the cathodal electrode, which is common at the 
beginning of stimulation.7 An expert panel have provided rec-
ommendations for clinical and research use which clearly set 
out safety parameters.18
The available data suggest that tDCS may reduce fatigue 
and improve sustained attention poststroke. However, there are 
no data on longer term effects of tDCS with regard to sus-
tained attention or clinical benefits, such as improved partici-
pation in rehabilitation, in older stroke survivors. We, therefore, 
designed the present study to test the hypothesis that tDCS 
applied to the DLPFC, compared with sham treatment, would 
be associated with an increase in the duration of rehabilitation 
therapy sessions in stroke survivors.
Materials and Methods
The study was approved by the Royal Perth Hospital Human 
Research Ethics Committee (2016-027) and prospectively reg-
istered (ACTRN12616000254493). An investigator provided 
all participants with a written information sheet, a simplified 
written summary of the information sheet designed for people 
experiencing communication impairments, and verbal infor-
mation about the study. All participants provided written 
informed consent.
Older adults (60+ years) admitted to the Bentley Hospital 
SRU with a diagnosis of ischaemic stroke, who clinical staff 
judged were likely to be inpatients ⩾1 month, were eligible to 
participate. Exclusion criteria included prestroke history of 
fatigue-related syndromes, unstable comorbid medical or psy-
chiatric disease, history of seizures or metallic foreign body 
implant, and use of NMDA receptor antagonists or calcium 
channel blockers (which limit the beneficial effect of tDCS). 
Participants were randomly allocated to receive 10 sessions (ie, 
each weekday for 2 weeks) of 2-mA anodal (excitatory) tDCS 
or sham tDCS, applied to the left DLPFC for 20 minutes. 
After a 2-day washout period, participants then crossed-over to 
the other study condition.
Transcranial direct current stimulation was applied 
within 1 hour prior to the first daily therapy session. 
Transcranial direct current stimulation was applied in 
accordance with published guidelines for the safe use of 
tDCS.5,18 Transcranial direct current stimulation was deliv-
ered by a constant current electric stimulator via a pair of 
rubber surface electrodes overlying a saline infused pad. 
The anode was applied to the left DLPFC (according to 
the International EEG 10/20 System),19 and the cathode 
was applied to the contralateral supraorbital area. Anodal 
stimulation consisted of a 30-second current ramp up fol-
lowed by 19 minutes of constant current stimulation (2 mA) 
and a 30-second ramp down to zero current (20-minute 
total protocol)10,20,21; sham stimulation consisted of a 
30-second current ramp up (2 mA) followed immediately 
by a 30-second ramp down to zero current. Researchers 
applying the tDCS and those recording measures were 
blinded to group allocation. Outcome measures were (a) 
whether the first rehabilitation therapy session of the day 
immediately following application of tDCS was completed 
as planned and (b) the cumulative duration (in minutes) of 
rehabilitation sessions.
We aimed to enrol at least 18 participants to provide 0.8 
power at the 0.05 level to detect a treatment effect of an increase 
in 17 minutes of therapy time with anodal tDCS compared 
with sham. Categorical frequency data (ie, sessions completed 
as planned) were categorised as ‘completed’ or ‘not complete’ 
and compared using the chi-square statistic. A paired sampled 
t test was used to determine within-subject differences in total 
therapy time according to group allocation.
Results
One hundred seventy consecutive patients were screened. The 
reasons for screen failure were length of stay anticipated to be 
⩽1 month (n = 64), diagnosis not ischaemic stroke (n = 48), 
treatment with calcium channel blockers (n = 16), which inter-
fere with tDCS effects, and other (n = 13). Ten patients declined 
participation. The 19 remaining participants (13 female; 6 
male; median age 79 [70.5, 82.5] years) were recruited.
The total number of planned first therapy sessions com-
pleted did not vary according to group allocation (111 of 139 
therapy sessions completed as planned following tDCS cf 110 
of 147 therapy sessions completed as planned in the sham con-
dition; chi-square 1.0; P = .31). Similarly, the proportion of 
patients completing all first therapy sessions of the day was not 
different according to group allocation (4 of 16 participants 
receiving tDCS; 8 of 18 participants receiving sham; 
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chi-square = 1.4; P = .24). The within-subject difference in 
therapy time according to sequence allocation was 25 minutes 
(95% confidence interval [CI] −80, 130; P = .61).
Discussion
This research evaluated a novel use of an established therapeu-
tic intervention (tDCS) to address an area of high clinical 
need, namely optimising the ability of older adults to engage 
in rehabilitation poststroke. We found that use of tDCS is fea-
sible in a clinical setting of subacute stroke rehabilitation but 
did not find evidence of increased engagement in therapy in 
this clinical population. There are a number of potential rea-
sons for this finding. Stroke is a heterogeneous disease, and it 
is possible that subgroups of stroke survivors may have bene-
fitted from the intervention, but this was not able to be identi-
fied due to the small sample size of this feasibility study. 
Individuals who were in the subacute recovery phase post-
stroke who were anticipated to be able to complete the inter-
vention as an inpatient (minimum 1-month length of stay) 
were recruited. These patients tend to have severe lesions and 
poststroke deficits; consequently, the findings may not be gen-
eralisable to other stroke survivors, or to stroke survivors ear-
lier in the course of their recovery. We did not specify inclusion 
of patients with a specific aetiology of ischaemic stroke; how-
ever, none of the included patients had a diagnosis of haemor-
rhage. It could also be the case that the dose of treatment (10 
sessions, which we judged would be feasible in a cross-over 
design) in our study was insufficient, given that some previous 
studies have used up to 30 sessions, and that there are some 
data10 supporting a dose-response relationship. Similarly, we 
chose a 2-day washout, which may have been insufficient. 
Future studies may consider use of a higher numbers of ses-
sions over a longer time period or tDCS applied simultane-
ously with rehabilitation intervention. Finally, we used a 
clinical endpoint (duration of rehabilitation sessions) as the 
primary outcome. More sensitive measures of sustained atten-
tion, fatigue, and other factors limiting participation in ther-
apy, including self-report measures, may be required to 
demonstrate benefits in subgroups of stroke survivors with 
fatigue/attention deficits.
The strengths of our study are that participants and asses-
sors were blinded to group allocation, and the inclusion of a 
sham condition, so that participants acted as their own control. 
The major limitation of our study is the potential for random 
error, and limited generalisability, because of the small number 
of participants. These limitations are unfortunately common in 
many of the studies in this field. There were also methodologi-
cal limitations; eg, we did not confirm successful blinding. 
Further studies with carefully selected subgroups of stroke sur-
vivors should be considered. Measurement of fatigue and 
attention at multiple time points in each 24-hour period would 
have been desirable, but was not possible in this feasibility 
study. This study shows that tDCS is feasible for in-patients, 
and future work should directly measure fatigue and attention 
to understand whether tDCS can increase engagement in ther-
apy via reduction in fatigue and increase in attention.
In conclusion, to our knowledge, this is the first study to 
explore the use of tDCS to specifically improve attention and 
reduce the effect of fatigue on treatment tolerance in older 
stroke survivors. Our results suggest that, while tDCS to the 
DLPFC was feasible to apply during subacute stroke rehabili-
tation, and was well tolerated, it did not significantly influence 
fatigue or alertness which are major contributors to a patient’s 
engagement in therapy. Larger studies are needed to make 
definitive conclusions about any potential benefit of tDCS to 
the DLPFC on alertness poststroke in older stroke survivors.
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